Keywords: galvus, gets, positive, opinion, chmp, swiss, drug

Galvus gets positive opinion from CHMP

Article | 24 December 2007

Print This

Swiss drug major Novartis has received a positive opinion recommending European Union approval of Galvus (vildagliptin) as a new, once-daily ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in